Cyprus - Re-Export of Penicillins or Streptomycins in Dosage Forms
Since 2014, Cyprus Re-Export of Penicillins or Streptomycins in Dosage Forms increased 16.2% year on year. In 2019, the country was ranked number 9 among other countries in Re-Export of Penicillins or Streptomycins in Dosage Forms with $401,376.21. Cyprus is overtaken by Canada, which was number 8 with $454,407.09 and is followed by New Zealand with $343,459.3. Italy lead the ranking with $158,707,704.07 in 2019, a decrease of 22% compared to 2018. United States, United Arab Emirates and Saudi Arabia respectively ranked number 2, 3 and 4 in this ranking. Kenya recorded the best 5 years average growth at +205.7% per year, while Trinidad and Tobago witnessed the worst performance at -27.8% per year.
Loading...
Date | US Dollars |
---|---|
2019 | 401,376.21 |
2018 | 282,546.19 |
2017 | 457,660.09 |
2016 | 1,086,114.00 |
2015 | 428,470.72 |
How does Cyprus rank in Re-Export of Penicillins or Streptomycins in Dosage Forms?
# | 27 Countries | US Dollars | Last | YoY | 5‑years CAGR | ||
---|---|---|---|---|---|---|---|
1 |
#1
Italy
|
158,707,704.07 | 2019 | -22.0 % | +57.7 % | View data | |
2 |
#2
United States
|
21,398,977.04 | 2019 | +3.5 % | +117.4 % | View data | |
8 |
#8
Canada
|
454,407.09 | 2019 | +193.1 % | +165.4 % | View data | |
9 |
#9
Cyprus
|
401,376.21 | 2019 | +42.1 % | +16.1 % | View data | |
10 |
#10
New Zealand
|
343,459.30 | 2019 | -4.0 % | +9.9 % | View data |